Joseph K.  Schachle net worth and biography

Joseph Schachle Biography and Net Worth

Mr. Schachle brings more than 30 years of experience in life sciences to his role as Chief Operating Officer of Opus, with specific expertise in strategic and operational planning, business development, marketing and sales, and business intelligence. Before joining Opus, Mr. Schachle served as vice president of Customer Experience Enablement and vice president of global commercial services and controlling at Grifols, where he led multiple commercial departments across business units, managed key cross-divisional initiatives and directed strategic brand planning process. Previously, Mr. Schachle was the COO for Parion Sciences, and part of the team that secured partners for the company’s lead programs, which exceeded $1 billion in deal value. Mr. Schachle has also served as chief commercial officer for Inspire Pharmaceuticals, where he oversaw multiple partnering deals and promoted three eye care brands, including AzaSite®, Elestate®, and Restasis®. In addition, he’s held multiple sales and marketing leadership positions at GlaxoSmithKline, where he managed several billion-dollar brands including Advair®, Imitrex®, Wellbutrin SR®, Epivir® / Retrovir® and Combivir®. He also served on the Board of Directors for the Council for Entrepreneurial Development (CED) and North Carolina State University College of Management Industry Advisory Board. Mr. Schachle earned his undergraduate degree from James Madison University and his MBA from Old Dominion University.

What is Joseph K. Schachle's net worth?

The estimated net worth of Joseph K. Schachle is at least $1.51 million as of April 23rd, 2026. Schachle owns 296,084 shares of Opus Genetics stock worth more than $1,512,989 as of April 30th. This net worth evaluation does not reflect any other investments that Schachle may own. Learn More about Joseph K. Schachle's net worth.

How do I contact Joseph K. Schachle?

The corporate mailing address for Schachle and other Opus Genetics executives is 37000 GRAND RIVER AVE. SUITE 120, FARMINGTON HILLS MI, 48335. Opus Genetics can also be reached via phone at 248-957-9024 and via email at [email protected]. Learn More on Joseph K. Schachle's contact information.

Has Joseph K. Schachle been buying or selling shares of Opus Genetics?

During the past quarter, Joseph K. Schachle has sold $24,518.34 in Opus Genetics stock. Most recently, Joseph K. Schachle sold 4,697 shares of the business's stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $5.22, for a transaction totalling $24,518.34. Following the completion of the sale, the chief operating officer now directly owns 296,084 shares of the company's stock, valued at $1,545,558.48. Learn More on Joseph K. Schachle's trading history.

Who are Opus Genetics' active insiders?

Opus Genetics' insider roster includes Robert Gagnon (CFO), Cam Gallagher (Director), Cam Gallagher (Director), Ashwath Jayagopal (Insider), George Magrath (CEO), Joseph Schachle (COO), Benjamin Yerxa (President), Benjamin Yerxa (President), and Rabourn Zaremba (Insider). Learn More on Opus Genetics' active insiders.

Are insiders buying or selling shares of Opus Genetics?

During the last year, Opus Genetics insiders bought shares 2 times. They purchased a total of 164,000 shares worth more than $323,890.00. During the last year, insiders at the sold shares 11 times. They sold a total of 4,073,395 shares worth more than $8,982,278.31. The most recent insider tranaction occured on April, 23rd when President Benjamin R Yerxa sold 7,470 shares worth more than $39,142.80. Insiders at Opus Genetics own 11.7% of the company. Learn More about insider trades at Opus Genetics.

Information on this page was last updated on 4/23/2026.

Joseph K. Schachle Insider Trading History at Opus Genetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/23/2026Sell4,697$5.22$24,518.34296,084View SEC Filing Icon  
3/16/2026Sell3,719$5.25$19,524.75300,781View SEC Filing Icon  
See Full Table

Joseph K. Schachle Buying and Selling Activity at Opus Genetics

This chart shows Joseph K Schachle's buying and selling at Opus Genetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Opus Genetics Company Overview

Opus Genetics logo
Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.
Read More

Today's Range

Now: $5.11
Low: $4.70
High: $5.23

50 Day Range

MA: $4.74
Low: $3.39
High: $5.75

2 Week Range

Now: $5.11
Low: $0.90
High: $5.81

Volume

1,436,817 shs

Average Volume

905,997 shs

Market Capitalization

$364.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52